Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elizabeth M. Bengtson
Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Profile of Obinutuzumab for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
OncoTargets and Therapy
Oncology
Pharmacology
A Phase I Study of Tipifarnib Combined With Conventional Induction and Consolidation Therapy for Previously Untreated Patients With Acute Myeloid Leukemia Aged 60 Years and Over
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
A Breakthrough Therapy in Relapsed Chronic Lymphocytic Leukemia: The Combination of Idelalisib and Rituximab
Postdoc journal
Update on Therapy of Chronic Lymphocytic Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Cost-Effectiveness of Adding Rituximab to Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia in Ukraine
Cancer Management and Research
Oncology
Humoral Immune Responses Toward Tumor-Derived Antigens in Previously Untreated Patients With Chronic Lymphocytic Leukemia
Oncotarget
Oncology
Filgrastim and Alemtuzumab (Campath-1h) for Refractory Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Frontline Therapy for Chronic Lymphocytic Leukemia: The Dilemma Continues
Clinical Cancer Research
Cancer Research
Oncology
